{"analyses":[{"groupIds":["OG000"],"nonInferiorityComment":"The association between response and Ve at Week 10 was evaluated.","nonInferiorityType":"OTHER","pValue":"0.0863","statisticalMethod":"Logistic Regression"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0785","value":"0.2543"},{"groupId":"OG001","spread":"0.0888","value":"0.2671"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0871","value":"0.2444"},{"groupId":"OG001","spread":"0.0781","value":"0.2623"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Day -2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1209","value":"0.2564"},{"groupId":"OG001","spread":"0.0447","value":"0.2602"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1138","value":"0.2854"},{"groupId":"OG001","spread":"0.0727","value":"0.3126"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Day 5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1622","value":"0.3055"},{"groupId":"OG001","spread":"0.1425","value":"0.3105"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Week 5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1225","value":"0.2776"},{"groupId":"OG001","spread":"0.1596","value":"0.2726"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Week 10"}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"description":"The fractional volume of extravascular extracellular space (Ve) was used to evaluate clinical outcomes. The average for the distribution across the whole region of interest (ROI) was calculated as a summary measure for each data set.","dispersionType":"Standard Deviation","groups":[{"description":"Stratum A participants had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis.","id":"OG000","title":"A: Localized Resectable Disease"},{"description":"Stratum C participants had metastatic tumors.","id":"OG001","title":"C: Metastatic Tumors"}],"paramType":"MEAN","populationDescription":"The number analyzed at each time point differed due to missing observations at some of the time points","reportingStatus":"POSTED","timeFrame":"Baseline through Week 10","title":"Mean Ve","type":"SECONDARY","unitOfMeasure":"(unitless)"}